Afamelanotide (Scenesse) vs Melanotan I confusion
Research & educational use only. This content is not medical advice. Consult a qualified healthcare professional before using any peptide compound.
There is constant confusion here. Afamelanotide is an FDA-approved drug (Scenesse), delivered as a subcutaneous implant, to increase pain-free light exposure in erythropoietic protoporphyria. It is sometimes loosely called Melanotan I.
The approval is for that specific photoprotection indication, not cosmetic tanning. The fact that an approved alpha-MSH analog exists does not transfer safety or efficacy to unregulated tanning peptides.